In-licensing: Biotechnology & Gastrointestinal

Latest: Watch here for details of new products and services.

Our Products: Overview; Partnering Search; Company Profiling; Partneringtools; Reports; Partnering Consulting; Comparison
Forums: Visit our forums
Jobs: Visit our job site
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire New!
Contact us: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing Ltd
is a division of

Up-to-date access to technology licensing opportunities worldwide.

Displaying 1..4 of 4 - per page
Order by

Seeking late stage or currently marketed assets. More

Therapeutic drugs in late stage development (marketed, registered or in clinical trials) are sought to complement our product portfolio. More

Patent protected/ Innovative/ New products More

Pharmaceuticals for gastrointestinal diseases; preferably rx status More

Displaying 1..4 of 4 - per page
Order by

Industry sector: Assay systems; Diagnostic test systems; Gene therapy; Human diagnostics; Human therapeutics; Nanotechnology; Other; Research supplies; Stem cells
Therapeutic target: Appendicitis; Cholangitis, sclerosing; Colitis; Colitis, ulcerative; Constipation; Crohn's disease; Diarrhea; Dyspepsia; Electrolyte replacement; Emesis; Emesis, motion; Esophagitis; Flatulence; Food poisoning; Gastritis; Gastroesophageal reflux disorder; Gastrointestinal (other); Gastrointestinal secretions; Gastroprokinetic; Helicobacter pylori; Inflammatory bowel disease; Irritable bowel syndrome; Nausea; Pancreatitis; Ulcer; Ulcer, gastric; Ulcer, gastroduodenal; Ulcer, peptic
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Industry news: Pharmalicensing provides comprehensive industry coverage.